SIXPEX Tirzepatide 10mg

Mounjaro / Zepbound

Pack	10mg vial

Brand	Sixpex Labs

✓ Dramatic Weight Loss – Average 15-21% body weight reduction in clinical trials
✓ Powerful Appetite Suppression – Eliminates constant hunger and food cravings
✓ Superior to Semaglutide – More effective weight loss than Ozempic/Wegovy
✓ Improves Metabolic Health – Lowers blood sugar, improves insulin sensitivity
✓ Dual Mechanism – Works on both GLP-1 and GIP receptors for maximum results

$99.00

In stock

For Beginners

For Beginners	Yes

Popularity

Rating	★★★★★

Strength Gain

Strength Gains	☆☆☆☆☆

Mass Gain

Mass Gain	☆☆☆☆☆

For Women

For Women	Yes

Side Effects

Side Effects Profile	★★☆☆☆

Fat Loss

Weight Loss	★★★★★

Use Form

Intake	Subq

Why You Should Buy SIXPEX Tirzepatide 10mg at Steroiduck?

At Steroiduck, we are committed to offering you the best quality anabolic steroids, peptides, HGH and SARMs You can count on. Every product goes through rigorous testing in a laboratory because we believe that quality cannot be sacrificed. Our reputation is built on providing honest, discreet USA domestic shipping and trustworthy secure payment methods to keep your information safe. When you buy SIXPEX Tirzepatide 10mg with us, you’re not just getting some supplement – you’re getting a promise of ultimate satisfaction based on years of commitment to quality.

What It Does

Tirzepatide 5mg contains Tirzepatide at 10 milligrams per vial – a revolutionary dual GIP/GLP-1 receptor agonist that’s the most effective weight loss medication available. Originally developed by Eli Lilly and sold as Mounjaro (for diabetes) and Zepbound (for weight loss), Tirzepatide produces superior fat loss compared to all previous GLP-1 medications including semaglutide.

When you inject Tirzepatide, it mimics two natural hormones – GLP-1 and GIP – that regulate appetite, blood sugar, and metabolism. This dual action creates powerful appetite suppression, reduced food cravings, delayed gastric emptying (feeling full longer), and enhanced fat burning. Unlike stimulants or harsh diet drugs, Tirzepatide works with your body’s natural systems to make weight loss effortless.

Tirzepatide is injected subcutaneously once weekly on the same day each week. Dosing starts at 2.5mg weekly for 4 weeks, then increases gradually to maintenance doses of 5-15mg weekly. Within 2-3 weeks, you’ll notice dramatically reduced appetite, elimination of constant food thoughts, and effortless calorie reduction. Over 6-12 months, expect 15-21% total body weight loss – that’s 30-42 pounds for someone weighing 200 pound

Weight Loss Results

Clinical trials show 15-21% average body weight reduction over 72 weeks – this is unmatched by any other weight loss medication. At the highest doses (15mg), participants lost average of 21% body weight (42 pounds for 200-pound person). Even at lower doses (5mg), users lost 15% of body weight (30 pounds for 200-pound person). These results are 2-3x better than older GLP-1 drugs.

Powerful Appetite Suppression

The most noticeable effect within days – Tirzepatide dramatically reduces hunger signals. The constant food thoughts disappear. Cravings for junk food eliminate. You naturally eat less without willpower or suffering. Many users report feeling satisfied with 50-60% of their normal food intake. The appetite suppression makes dieting effortless rather than a battle.

Eliminates Food Noise

Users consistently report the “food noise” in their head goes silent. The constant mental chatter about food, the obsessive thinking about next meal, the inability to focus because of hunger – it all disappears. This psychological freedom is as valuable as the physical weight loss for many users.

Delayed Gastric Emptying

Tirzepatide slows stomach emptying significantly, meaning food stays in your stomach longer. This creates prolonged satiety – you feel full for 6-8 hours after small meals. The extended fullness makes intermittent fasting and calorie restriction sustainable long-term.

Improves Metabolic Health

Beyond weight loss, Tirzepatide dramatically improves insulin sensitivity, lowers blood sugar, reduces A1C in diabetics, and improves overall metabolic function. Even non-diabetic users see improved glucose control and reduced diabetes risk. The metabolic benefits persist even after weight loss ends.

Preserves Muscle Mass

Unlike crash dieting which burns significant muscle, Tirzepatide users maintain lean body mass better when combined with resistance training and adequate protein. The weight lost is predominantly fat tissue, not muscle. This creates better body composition outcomes.

Cardiovascular Benefits

Studies show improved blood pressure, reduced triglycerides, improved cholesterol profiles, and overall cardiovascular health improvements. The weight loss and metabolic benefits combine to significantly reduce cardiovascular disease risk.

Dosing Schedule (Standard Protocol):

Weeks 1-4: 2.5mg once weekly (starter dose)
Weeks 5-8: 5mg once weekly
Weeks 9-12: 7.5mg once weekly (optional escalation)
Weeks 13-16: 10mg once weekly (optional escalation)
Weeks 17-20: 12.5mg once weekly (optional escalation)
Week 21+: 15mg once weekly (maximum dose, optional)

When to Increase Dose:

Only increase every 4 weeks minimum - never increase more frequently or by more than 2.5mg at a time. Many users find optimal results at 5-10mg weekly without needing to reach 15mg maximum.

When to Inject:

Once weekly on the same day each week - set a consistent schedule (e.g., every Monday morning). Can inject at any time of day, with or without food. Rotate injection sites (abdomen, thigh, upper arm).

Injection Method:

Subcutaneous injection into fatty tissue (abdomen preferred) using insulin needle. Inject slowly. Rotate sites each week to prevent lipohypertrophy.

Reconstitution:

If using lyophilized powder: Mix 5mg powder with 2ml bacteriostatic water. This creates 2.5mg/ml concentration. Each 1ml = 2.5mg dose or 0.5ml = 1.25mg. Gently swirl until dissolved (do not shake).

Maintenance Strategy:

Once you reach goal weight, many users reduce to lowest effective maintenance dose (often 2.5-5mg weekly) to maintain weight loss without continuing escalation. Some users cycle off completely after reaching goal.

Most Common (Gastrointestinal):

Nausea (especially first 2-3 weeks or after dose increases)
Diarrhea or constipation
Stomach discomfort or pain
Vomiting (usually mild and temporary)
Indigestion or acid reflux
Reduced appetite (this is desired effect but can be intense)

Less Common:

Fatigue or low energy (especially initially)
Headaches
Dizziness
Injection site reactions (redness, itching)
Hair thinning (temporary, from rapid weight loss)

Serious Side Effects (Rare):

Pancreatitis (severe abdominal pain - discontinue immediately)
Gallbladder problems (gallstones from rapid weight loss)
Hypoglycemia (if combined with insulin or sulfonylureas)
Kidney problems (usually from dehydration)
Thyroid C-cell tumors (in animal studies, not confirmed in humans)

How to Manage:

Nausea: Take with food, eat smaller meals, avoid fatty/greasy foods, stay hydrated, consider anti-nausea medication. Improves significantly after 2-3 weeks. GI issues: Increase fiber, stay hydrated, eat slowly. Fatigue: Ensure adequate calories and protein despite reduced appetite. Dehydration risk: Drink minimum 8 glasses water daily. Get blood work checking kidney function and electrolytes if experiencing severe GI symptoms.

Active Ingredient: Tirzepatide - Dual GIP/GLP-1 receptor agonist peptide
Dosage Strength: 10 milligrams per vial
Quantity: Single vial (requires reconstitution if powder form)
Form: Lyophilized powder requiring reconstitution OR pre-mixed solution for injection

Intended Use:
Primary medical use: Type 2 diabetes management (Mounjaro), chronic weight management in obesity (Zepbound), obstructive sleep apnea with obesity.
Primary user applications: Fat loss, weight management, appetite control, metabolic health improvement, body recomposition.

Classification: Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist

Mechanism of Action: Tirzepatide is a 39-amino acid synthetic peptide that activates both GIP and GLP-1 receptors with higher affinity for GIP. GLP-1 activation causes: increased insulin secretion (glucose-dependent), decreased glucagon secretion, delayed gastric emptying, reduced appetite through CNS pathways, increased satiety. GIP activation causes: enhanced insulin secretion, direct CNS appetite suppression via hypothalamic receptors, improved fat metabolism, potential increased energy expenditure. The dual mechanism produces synergistic effects greater than GLP-1 activation alone, explaining superior weight loss versus semaglutide.

Molecular Weight: Approximately 4813 g/mol (39 amino acids)
Half-Life: Approximately 5 days (allows once-weekly dosing)
Time to Peak Plasma: 8-72 hours post-injection
Bioavailability: 80% subcutaneous bioavailability

Effects on Metabolism:

Reduces fasting and postprandial glucose
Increases insulin sensitivity
Reduces A1C by 1.5-2.5% in diabetics
Increases GLP-1 and GIP activity
Reduces appetite hormones (ghrelin)
Increases satiety hormones

Hepatotoxicity: None - not hepatotoxic
Renal Effects: Generally safe; ensure adequate hydration
Cardiovascular Effects: Positive - improves multiple CV risk factors

Administration: Subcutaneous injection into abdomen (preferred), thigh, or upper arm using insulin needle. Inject once weekly on consistent schedule. Rotate injection sites.

Storage: Must be refrigerated at 36-46°F (2-8°C) before and after reconstitution. Do not freeze. Protect from light. Use within 28 days of reconstitution. Can be kept at room temperature up to 21 days if needed.

Also Known As: Tirzepatide, Mounjaro (diabetes brand), Zepbound (weight loss brand), LY3298176

RELATED PRODUCTS

SaleSold out